FUJIFILM Irvine Scientific Introduces Sterile Express Media Service

/in , , , , /by

The first manufacturing service of its kind delivers tested sterile, non-GMP media designed for feasibility testing before scale-up, to support development of cell and gene therapies SANTA ANA, California: FUJIFILM Irvine Scientific, Inc., today announced the launch of Sterile Express Media Service (SEMS), for small-scale, rapid production of non-GMP media tested for sterility. With SEMS, customers […]

Read more →

Shimadzu Announces the Start of Its Blood-Based Amyloid Mass Spectrometry Service

/in , , /by

Dedicated to Drug Discovery and Development Shimadzu Scientific Instruments introduces the Amyloid Mass Spectrometry (MS) Service for early screening of amyloid-positive subjects. This simple blood analysis method enables early and accurate prediction of amyloid pathology in the brain with an easy-to-acquire blood sample. Although the screening analysis is Research Use Only and cannot diagnose Alzheimer’s […]

Read more →

Cellecta Introduces GeoMx Digital Spatial Profiling Service to Provide Novel Insights into Tumor Biology

/in , , /by

New RNA Spatial Profiling Service Allows Researchers to Access Advanced Technology and Extensive RNA Expertise in a Commercial Lab Setting MOUNTAIN VIEW, Calif.— Cellecta, Inc. today announced the launch of its new RNA Spatial Profiling Service using NanoString’s GeoMx®Cancer Transcriptome Atlas (CTA) on the GeoMx Digital Spatial Profiler. As one of the few designated GeoMx […]

Read more →

IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic Resistant Pathogens

/in , , /by

New Panel to Provide Support During Onset of Flu Season in the Midst of the COVID-19 Pandemic San Francisco, CA — As the world continues to battle COVID-19, health officials are preparing for the possibility of more co-infections with the onset of the Flu Season. Studies show a high frequency of co-infections in patients with […]

Read more →

Axol Bioscience introduces multi-electrode array screening services for human iPSC-derived cells

/in , , , , /by

 Expansion of Axol Bioscience’s service offering for pre-clinical drug discovery New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform Cambridge, UK: Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease-relevant cell-based assay systems to the drug discovery industry, today announced […]

Read more →